Samsung Biologics is participating in CPhI Worldwide 2021, which is taking place in-person from November 9-11, 2021 at Fiera Milano, Italy. As the world's largest pharmaceutical exhibition, CPhI Worldwide will be a host to more than 2,500 companies with more than 48,000 pharma industry leaders attending, providing an industry-leading setting to network and share insights.
The company will showcase its progresses and achievements at an independent exhibition booth. A panoramic display will be exhibited to highlight some of the key capabilities of Samsung Biologics as a leading CDMO. The core focuses will be, 'Samsung Biologics world's largest manufacturing capacity of 620,000L', 'S-Cellerate (CDO process platform to expedite timeline to IND and BLA)', 'Multi-modality for business portfolio expansion', and 'Offering of end-to-end, one-stop service'.
Samsung Biologics will follow the guidelines to help prevent the spread of COVID-19 and advise all attendees to be wearing masks when visiting the booth.
Samsung Biologics is participating in CPhI Worldwide 2021, which is taking place in-person from November 9-11, 2021 at Fiera Milano, Italy. As the world's largest pharmaceutical exhibition, CPhI Worldwide will be a host to more than 2,500 companies with more than 48,000 pharma industry leaders attending, providing an industry-leading setting to network and share insights.
The company will showcase its progresses and achievements at an independent exhibition booth. A panoramic display will be exhibited to highlight some of the key capabilities of Samsung Biologics as a leading CDMO. The core focuses will be, 'Samsung Biologics world's largest manufacturing capacity of 620,000L', 'S-Cellerate (CDO process platform to expedite timeline to IND and BLA)', 'Multi-modality for business portfolio expansion', and 'Offering of end-to-end, one-stop service'.
Samsung Biologics will follow the guidelines to help prevent the spread of COVID-19 and advise all attendees to be wearing masks when visiting the booth.
Share article
Related Content